Omega-3 fatty acids for intermittent claudication (Q24201333)

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Longchain n-3 polyunsaturated fatty acids and blood vessel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

ACP Journal Club: review: omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Omega 3 fatty acids for prevention and treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Polyunsaturated fatty acid supplementation for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Peripheral arterial disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Omega-3 fatty acids for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Herbal and dietary therapies for primary and secondary dysmenorrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Current medical therapies for patients with peripheral arterial disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Omega-3 fatty acids for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Omega-3 fatty acids for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Fish oil supplementation in patients with stable claudication

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Olive oil- and fish oil-enriched diets modify plasma lipids and susceptibility of LDL to oxidative modification in free-living male patients with peripheral vascular disease: the Spanish Nutrition Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Beneficial effect of fish oil on blood viscosity in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Secondary prevention for patients following a myocardial infarction: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021

Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003833.PUB4

7 January 2021